NSEPrice movement1d ago · 17 Sept 2026, 11:58 am
Price movement
Anlon Healthcare Limited · AHCL
✦ AI SummaryRegulatory
Anlon Healthcare Limited has responded to the Exchange's query regarding significant price movement in its securities, stating that the company is not aware of any information or event that may have a bearing on the price movement and has been complying with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Significant movement in price has been observed in Anlon Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Anlon Healthcare Limited has submitted their response.
Attachments (1)
📄pdf
Download →
ANLON2013_17092026115832_AHLClarificationonPriceMovement17092026Signed.pdf
View document text
September 17, 2026
To, To,
Listing Department, The National Stock Exchange of India
BSE Limited Ltd.
Phiroze Jeejeebhoy Towers, The Listing Department
Dalal Street, Exchange Plaza,
Mumbai – 400 001 Bandra – Kurla Complex,
Ref: BSE Scrip Code: 544497 Mumbai – 400051,
NSE Scrip Code: AHCL
Sub: Clarification on significant movement in the price of Anlon Healthcare
Limited- BSE Letter Ref. No.: - L/SURV/ONL/PV/SJ/ 2026-2027 / 4262 dated
September 16, 2026 and NSE Ref. No.: NSE/CM/Surveillance/17555 dated
September 16, 2026
RE: Intimation under Regulation 30 of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI Listing Regulations 2015”)
Dear Sir/Madam,
With reference to the communication received from the Exchange regarding the
significant movement in the price of the securities of Anlon Healthcare Limited
(“Company”), we wish to clarify that the Company is not aware of any information or
event which, in its opinion, may have a bearing on the price movement of its securities
and which has not already been disclosed to the Stock Exchange.
In this regard, we wish to inform you that the Company has been strictly complying
with provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 by filing relevant Disclosures / Announcement within
stipulated time period in past and confirm to have disclosed all information(s) /
announcement(s) required to be disclosed as and when it is required. There is no
pending information or announcement from the Company which may have a bearing
on the price/volume behavior of the Company's security.
We further wish to clarify that the movement in the market price of the Company’s
securities is purely market-driven and may be attributable to various factors, including
market conditions, investor sentiment, trading activity and other factors beyond the
control of the Company.
We hope the above clarifies your concern and request you to kindly take the same on
your record.
You are requested to take the above information on your record.
Thanking You.
For ANLON HEALTHCARE LIMITED
PUNITKUMAR RASADIA
MANAGING DIRECTOR
DIN: 06696258
ANLON HEALTHCARE LIMITED
CIN No.: L24230GJ2013PLC077543
REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road,
Rajkot-360005, Gujarat (INDIA)
PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in